KELLI MCCALL: Open Payments
NPI 1023480274 · KERRVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 76 payments from 16 companies in 2025. Trend: 2023 $58 · 2024 $372 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 30 | $284 |
| ABBVIE INC. | 21 | $274 |
| Novartis Pharmaceuticals Corporation | 3 | $76 |
| ACADIA Pharmaceuticals Inc | 4 | $69 |
| Biogen, Inc. | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| GE HEALTHCARE | 2 | $47 |
| Lilly USA, LLC | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| Cycle Pharmaceuticals Inc | 1 | $29 |
Products named: NURTEC ODT, QULIPTA, UBRELVY, KESIMPTA, NUPLAZID, HYQVIA, TYSABRI, LEQEMBI.
Industry payments across TX — which companies pay providers there.
